Opus Capital Group LLC lowered its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,375 shares of the pharmacy operator’s stock after selling 200 shares during the period. Opus Capital Group LLC’s holdings in Walgreens Boots Alliance were worth $436,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. HL Financial Services LLC raised its holdings in shares of Walgreens Boots Alliance by 16.4% during the 4th quarter. HL Financial Services LLC now owns 299,934 shares of the pharmacy operator’s stock valued at $20,495,000 after purchasing an additional 42,155 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in Walgreens Boots Alliance by 23.1% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 6,806 shares of the pharmacy operator’s stock worth $465,000 after acquiring an additional 1,279 shares during the period. Whittier Trust Co. raised its holdings in Walgreens Boots Alliance by 94.1% in the 4th quarter. Whittier Trust Co. now owns 20,418 shares of the pharmacy operator’s stock worth $1,395,000 after acquiring an additional 9,900 shares during the period. Westpac Banking Corp raised its holdings in Walgreens Boots Alliance by 13.0% in the 4th quarter. Westpac Banking Corp now owns 128,170 shares of the pharmacy operator’s stock worth $8,758,000 after acquiring an additional 14,700 shares during the period. Finally, InterOcean Capital LLC raised its holdings in Walgreens Boots Alliance by 2.9% in the 4th quarter. InterOcean Capital LLC now owns 12,245 shares of the pharmacy operator’s stock worth $837,000 after acquiring an additional 340 shares during the period. 63.55% of the stock is owned by institutional investors.

NASDAQ WBA opened at $71.80 on Thursday. The company has a current ratio of 0.80, a quick ratio of 0.36 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $70.22 billion, a price-to-earnings ratio of 12.01, a P/E/G ratio of 1.16 and a beta of 0.98. Walgreens Boots Alliance Inc has a 52-week low of $59.07 and a 52-week high of $86.31.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.43 by $0.03. The company had revenue of $33.79 billion for the quarter, compared to analyst estimates of $33.90 billion. Walgreens Boots Alliance had a net margin of 3.96% and a return on equity of 22.17%. The business’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period last year, the business posted $1.28 EPS. Research analysts forecast that Walgreens Boots Alliance Inc will post 6.52 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Friday, February 15th will be given a $0.44 dividend. The ex-dividend date is Thursday, February 14th. This represents a $1.76 annualized dividend and a yield of 2.45%. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.

WBA has been the topic of several recent analyst reports. Needham & Company LLC upgraded shares of Walgreens Boots Alliance to a “buy” rating and set a $94.00 target price on the stock in a report on Thursday, December 20th. Loop Capital set a $82.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Thursday, December 20th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $92.00 target price on the stock in a report on Friday, November 30th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 18th. Finally, Morgan Stanley lifted their target price on shares of Walgreens Boots Alliance from $55.00 to $77.00 and gave the stock an “equal weight” rating in a report on Monday, December 3rd. Three investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $78.83.

ILLEGAL ACTIVITY WARNING: “Opus Capital Group LLC Decreases Holdings in Walgreens Boots Alliance Inc (WBA)” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.watchlistnews.com/opus-capital-group-llc-decreases-holdings-in-walgreens-boots-alliance-inc-wba/2837427.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: Quiet Period Expirations

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.